Lv3
360 积分 2022-07-20 加入
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
2个月前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
2个月前
已完结
The validity and utility of the Cutaneous Disease Area and Severity Index (CDASI) as a clinical outcome instrument in dermatomyositis: A comprehensive review
2个月前
已完结
Translational research in pulmonary fibrosis
2个月前
已完结
Pulmonary fibrosis: from pathogenesis to clinical decision-making
2个月前
已完结
Clinical progress of engineered cellular immunotherapies for autoimmunity
2个月前
已完结
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study
2个月前
已完结
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study
2个月前
已完结
Treatment strategies for patients with diffuse large B-cell lymphoma
3个月前
已完结
CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift?
3个月前
已完结
皖公网安备34019202002308
